These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7684 related articles for article (PubMed ID: 2206779)

  • 41. [Monoclonal antibody MIA15-5, which inhibits cell motility and metastatic potential, has a great effect on the prognosis of the post-surgical patients with lung cancer].
    Miyake M; Taki T; Hakomori S
    Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1102-6. PubMed ID: 1719365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cordycepin (3'-deoxyadenosine) on hematogenic lung metastatic model mice.
    Nakamura K; Konoha K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    In Vivo; 2005; 19(1):137-41. PubMed ID: 15796166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin.
    Platt D; Raz A
    J Natl Cancer Inst; 1992 Mar; 84(6):438-42. PubMed ID: 1538421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ethanol modulates metastatic potential of B16BL6 melanoma and host responses.
    Blank SE; Meadows GG
    Alcohol Clin Exp Res; 1996 Jun; 20(4):624-8. PubMed ID: 8800377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis.
    Miyake M; Hakomori SI
    Biochemistry; 1991 Apr; 30(13):3328-34. PubMed ID: 2009271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.
    Timmons JJ; Cohessy S; Wong ET
    J Vis Exp; 2016 May; (111):. PubMed ID: 27285567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth in an organ microenvironment as a selective process in metastasis.
    Price JE; Naito S; Fidler IJ
    Clin Exp Metastasis; 1988; 6(1):91-102. PubMed ID: 2961497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New variants of the B16 melanoma: tumorigenicity and metastatic properties under different culture conditions.
    Aubert C; Rougé F; Voulot C
    J Natl Cancer Inst; 1990 Jun; 82(11):952-8. PubMed ID: 2342130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metastatic phenotype in hybrid cells derived from B16 melanoma.
    Ito M; Izuhara M; Shimizu K; Sekiguchi M
    Cancer Lett; 1994 Apr; 78(1-3):33-9. PubMed ID: 8180966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large scale biosynthesis of ganglioside analogues by RERF-LC-AI cells cultured in HYPERFlask.
    Shimura Y; Suzuki J; Muraoka M; Kasuya MC; Matsuoka K; Hatanaka K
    Prep Biochem Biotechnol; 2012; 42(4):378-92. PubMed ID: 22708814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative.
    Allegrucci M; Fuschiotti P; Puccetti P; Romani L; Fioretti MC
    Clin Exp Metastasis; 1989; 7(3):329-41. PubMed ID: 2924449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia.
    Stackpole CW; Groszek L; Kalbag SS
    J Natl Cancer Inst; 1994 Mar; 86(5):361-7. PubMed ID: 8308928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6.
    Saito M; Kishi R; Sasai T; Hatakenaka T; Matsuki N; Minagawa S
    Mol Cell Biochem; 2021 Jul; 476(7):2651-2661. PubMed ID: 33665763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azido glycoside primer: a versatile building block for the biocombinatorial synthesis of glycosphingolipid analogues.
    Kasuya MC; Wang LX; Lee YC; Mitsuki M; Nakajima H; Miura Y; Sato T; Hatanaka K; Yamagata S; Yamagata T
    Carbohydr Res; 2000 Dec; 329(4):755-63. PubMed ID: 11125817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effect of host microenvironment and systemic humoral factors on the implantation and the growth rate of metastatic tumor in parabiotic mice constructed between young and old mice.
    Hirayama R; Takemura K; Nihei Z; Ichikawa W; Takagi Y; Mishima Y; Utsuyama M; Hirokawa K
    Mech Ageing Dev; 1993 Oct; 71(3):213-21. PubMed ID: 8133677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in organization of metastatic and nonmetastatic tumors initiated by the same B16 melanoma clone in mature and young mice.
    Stackpole CW; Alterman AL; Angadi CV; Kim YS; Fornabaio DM
    Clin Exp Metastasis; 1990; 8(3):255-66. PubMed ID: 2328546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of pre-operative blood transfusion on tumour metastases.
    Clarke PJ; Tarin D
    Br J Surg; 1987 Jun; 74(6):520-2. PubMed ID: 3607415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs.
    Glinsky GV; Mossine VV; Price JE; Bielenberg D; Glinsky VV; Ananthaswamy HN; Feather MS
    Clin Exp Metastasis; 1996 May; 14(3):253-67. PubMed ID: 8674280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carbohydrate-lysyllysine conjugates as cell antiadhesion agents.
    Toyokuni T; Hakomori S
    Methods Enzymol; 1994; 247():325-41. PubMed ID: 7898361
    [No Abstract]   [Full Text] [Related]  

  • 60. Investigation of tumor metastatic potential with N-[18F]fluoroacetyl-D-glucosamine.
    Kubota K; Ishiwata K; Tada M; Yamada S; Kubota R; Iwata R; Sato K; Kimata K; Ido T
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):747-52. PubMed ID: 1399695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 385.